The Trilogy+ facility can be deployed on the hospital site or in a community setting, enabling endoscopists to perform a range of diagnostic and therapeutic procedures, with the capacity to deliver +24 JAG points per day.
Surge in demand
The Trilogy+ facility will prove a key resource for NHS trusts as the demand for endoscopy services rises substantially.
Keith Austin, chief executive at EMS Healthcare, said: “Each year almost 42,000 people are diagnosed with bowel cancer, making it the fourth-most-common cancer in the UK.
"The National Screening Committee now recommends bowel cancer screenings to begin at the age of 50 – lowered from 60. In April 2020, the Faster Diagnosis Standard is also set to come into effect, with NHS trusts expected to give a definitive diagnosis on cancer within 28 days of referral.
"These are really positive steps that can potentially save thousands of lives. And we simply cannot have patients facing delays to receive potentially life-saving diagnostic tests.”
The Trilogy+ facility is designed and built to the latest
The self-contained layout provides trusts with a complete endoscopy solution, from procedure through to decontamination.
It includes a private consultation room, three recovery bays, two seated recovery areas, a nursing station, reception area, bathroom, and a spacious decontamination suite.
There is also a procedure room fitted with a fully-integrated piped medical gas system, with CO2, Entonox, oxygen and suction (HTM 02-01 compliant).
Utilising state-of-the-art decontamination equipment, provided by Cantel UK, the unit can reprocess up to six scopes per hour, ensuring the minimum amount of scopes are required to deliver a cost-effective and efficient service.
And, to ensure everything keeps running, the unit is backed by a Gold Planned Preventative Maintenance (PPM) contract.
Redefining standards within the mobile healthcare industry
Austin says, “The unit matches the latest facilities found onsite at hospitals, and, crucially, prioritises the patient experience.
“It will provide trusts which much-needed additional scoping capacity in light of the updated screening requirements, and we’re really looking forward to announcing our first NHS trust partner in the coming months.”